ArticleInternational journal of clinical oncology2026
Association between response to gemcitabine-based neoadjuvant therapy and efficacy of gemcitabine plus nab-paclitaxel for recurrent pancreatic ductal adenocarcinoma.
Takumi Kinomoto et al.PubMed ↗Publisher ↗
No numbers read from the abstract.